Usana Health Sciences (USNA) Cash from Investing Activities (2011 - 2026)

Usana Health Sciences (USNA) has reported Cash from Investing Activities for 16 consecutive years, with -$2.6 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash from Investing Activities rose 32.98% year-over-year to -$2.6 million; the TTM figure through Apr 2026 stood at -$8.8 million (up 95.84% YoY), while the FY2026 annual figure was -$10.1 million, up 95.25% from the prior year.
• Cash from Investing Activities slipped to -$2.6 million in Q2 2026 per USNA's latest filing, from $1.1 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $1.1 million in Q1 2026 and bottomed at -$205.1 million in Q4 2024.
• Historically, Cash from Investing Activities has averaged -$14.0 million across 5 years, with a median of -$3.2 million in 2022.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 104.81% — and 2024, when it plunged 2701.67%.
• Usana Health Sciences' Cash from Investing Activities stood at -$3.3 million in 2022, then tumbled by 123.1% to -$7.3 million in 2023, then slumped by 2701.67% to -$205.1 million in 2024, then soared by 98.44% to -$3.2 million in 2025, then advanced by 18.79% to -$2.6 million in 2026.
• Business Quant data shows USNA's Cash from Investing Activities at -$2.6 million in Q2 2026, $1.1 million in Q1 2026, and -$3.2 million in Q3 2025.